Results 21 to 30 of about 3,193,060 (260)

Vaginal metastasis in solid tumours: our four cases and review of the literature

open access: yesJournal of the Egyptian National Cancer Institute, 2021
Background Vaginal metastasis should be kept in mind when evaluating the staging tests of all cancers, especially endometrial cancer. Case presentation We present four patients with vaginal recurrence who recently applied to our clinic.
Mustafa Korkmaz   +6 more
doaj   +1 more source

POSTCOITAL BLEEDING IN WOMEN ATTENDING A TERTIARY CARE HOSPITAL

open access: yesPakistan Armed Forces Medical Journal, 2006
Objective: To document the frequency of different pathologies in women with postcoital bleeding. To determine the frequency whether abnormal bleeding with positive cervical smear increases the risk of serious pathology. Design: Descriptive study. Place
Naila Bangash`
doaj   +2 more sources

Pembrolizumab in Vaginal Carcinoma: A Case Report and Review of the Literature

open access: yesCase Reports in Oncology
Introduction: Vaginal cancer is a rare gynecologic malignancy. While in a localized disease, concurrent chemoradiation grants local control and better overall survival, in a metastatic setting, the management options are very limited.
Maria Giuseppa Vitale   +10 more
doaj   +1 more source

Association between common vaginal and HPV infections and results of cytology test in the Zhoupu District, Shanghai City, China, from 2014 to 2019

open access: yesVirology Journal, 2022
Background HPV (human papillomavirus) is an important cause of cervical cancer. Cervical-vaginal infection with pathogens, such as herpes simplex virus (HSV), bacterial vaginosis Trichomonas vaginalis and vaginal candidiasis could be a cofactor.
Huaping Li   +9 more
doaj   +1 more source

Childhood, adolescent and young adult cancer: cancer trends report

open access: yes, 2023
This is the third Cancer Trends Report the National Cancer Registry Ireland (NCRI) has published on childhood cancers and the first to include cancers in adolescents and young adults (AYA) (up to 24 years of age).
National Cancer Registry Ireland (NCRI)
core  

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani   +7 more
wiley   +1 more source

The human gut microbiome across the life course

open access: yesFEBS Letters, EarlyView.
Despite significant individual variation and continuous change throughout life, the human gut microbiome follows some life stage‐specific trends. This article provides a brief overview of how gut microbiome composition shifts across different phases of life. Created in BioRender. Özkurt, E. (2026) https://BioRender.com/8q4nrnc.
Alise J. Ponsero   +4 more
wiley   +1 more source

The role of microbiota in the etiology of dysplastic and oncological diseases of the cervix, vagina, and vulva: A review

open access: yesГинекология
The vaginal microbiota of a healthy woman is a unique microecosystem comprising more than 300 bacterial species. The main vaginal bacteria of a healthy woman are Lactobacillus spp. (90–95%), with the most common being L. crispatus, L. iners, L. jensenii,
A. N. Mgeryan   +4 more
doaj   +1 more source

The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy. [PDF]

open access: yes, 2003
To assess the efficacy of 2% clindamycin vaginal cream (CVC) to treat bacterial vaginosis (BV) in ...
Sheehan, M   +4 more
core   +1 more source

HER3 Is an Actionable Target in Advanced Prostate Cancer.

open access: yes, 2021
It has been recognized for decades that ERBB signaling is important in prostate cancer, but targeting ERBB receptors as a therapeutic strategy for prostate cancer has been ineffective clinically.
Bertan, C   +44 more
core   +1 more source

Home - About - Disclaimer - Privacy